Personalised drugs tear up cancer's death warrants
More than 70 new cancer drugs have come to market, and describing some of them as revolutionary is not hyperbole.
More than 70 new cancer drugs have come to market, and describing some of them as revolutionary is not hyperbole.
The regulation around private health insurance is a mess, driving up premiums for members, half of whom earn less than $50,000 a year.
Critics accuse super fund of ripping off thousands of members with fine-print exclusions.
The case of how one REST Industry Super member was denied a payout on her disability insurance highlights much broader problems in the system.
Heritage and "character" houses are being destroyed, slicing billions off streets' value.
Workers are getting slugged with higher insurance premiums via their superannuation fees, prompting the regulator and other industry experts to question if they are getting value for money.
Wealth protection is far less sexy than wealth building, but it's critically important if you want control over where your assets go.
Nib chief executive Mark Fitzgibbon says device makers have "siphoned off" $1 billion a year in excess profit.
Driven by faith in technology rather than science, Australian men are lining up for robotic surgery for prostate cancer.
Adrian Gore began winning after an epiphany "people aren't rational" about their health.
Medibank Private has appointed Craig Drummond as chief executive effective on July 4 after an "extensive global search", the health insurer ...
Unlimited access to business news and market insights across any device
Already a subscriber? Log in